Triméthoprime

Triméthoprime may be available in the countries listed below.

Ingredient matches for Triméthoprime

Trimethoprim

Triméthoprime (DCF) is known as Trimethoprim in the US.

International Drug Name Search

Glossary

DCF	Dénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Novolog

Novolog is a brand name of insulin aspart, approved by the FDA in the following formulation(s):

NOVOLOG (insulin aspart recombinant - injectable; subcutaneous)

• 
  Manufacturer: NOVO NORDISK INC
  
  Approval date: June 7, 2000
  
  Strength(s): 100 UNITS/ML ^[RLD]

Has a generic version of Novolog been approved?

No. There is currently no therapeutically equivalent version of Novolog available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Novolog. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Insulin analogues
  Patent 5,618,913
  Issued: April 8, 1997
  Inventor(s): Brange; Jens J. V. & Norris; Kjeld & Hansen; Mogens T.
  Assignee(s): Novo Nordisk A/S
  Novel rapid-acting human insulin analogues are provided having less tendency to self-association into dimers, tetramers, hexamers, or polymers. The novel human insulin analogues are formed by substituting one or more of the amino acid residues of human insulin with naturally occuring amino acid residues. The amino acid residue substitutions are preferably more hydrophilic than the natural amino acid residue at the respective position in the molecule. Furthermore, the insulin analogues have the same charge or a greater negative charge at neutral pH than that of human insulin. Preferred amino acid substitutions are Asp, Glu, Ser, Thr, His, and Ile, and more preferred substitutions are Asp and Glu. The novel insulin analogues can be used for the preparation of rapid-acting insulin solutions.
  
  Patent expiration dates:
  
  
  • June 7, 2014
    
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  
  
  • December 7, 2014
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Insulin preparations containing NaCl
  Patent 5,866,538
  Issued: February 2, 1999
  Inventor(s): Norup; Elsebeth & Langkj.ae butted.r; Liselotte & Havelund; Svend
  Assignee(s): Novo Nordisk A/S
  Insulin preparations of superior chemical stability, comprising human insulin or an analogue or derivative thereof, glycerol and/or mannitol, and 5 to 100 mM of a halogenide are disclosed.
  
  Patent expiration dates:
  
  
  • June 20, 2017
    
  
  
  
  • December 20, 2017
    
    ✓ 
    Pediatric exclusivity
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • March 14, 2011 - PROVIDES FOR PEDIATRIC PUMP USE
  
  

See also...

• NovoLog Consumer Information (Drugs.com)
• NovoLog Cartridges Consumer Information (Wolters Kluwer)
• NovoLog Vials Consumer Information (Wolters Kluwer)
• NovoLog Consumer Information (Cerner Multum)
• Novolog Advanced Consumer Information (Micromedex)
• Novolog AHFS DI Monographs (ASHP)
• Insulin Aspart Cartridges Consumer Information (Wolters Kluwer)
• Insulin Aspart Vials Consumer Information (Wolters Kluwer)
• Insulin aspart Consumer Information (Cerner Multum)
• Insulin aspart, recombinant Subcutaneous Advanced Consumer Information (Micromedex)
• Insulin Aspart AHFS DI Monographs (ASHP)

Ambrosol

Ambrosol may be available in the countries listed below.

Ingredient matches for Ambrosol

Ambroxol

Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Ambrosol in the following countries:

• Poland

International Drug Name Search

Nicergolin

Nicergolin may be available in the countries listed below.

Ingredient matches for Nicergolin

Nicergoline

Nicergoline is reported as an ingredient of Nicergolin in the following countries:

• Poland

International Drug Name Search

Piromed

Piromed may be available in the countries listed below.

Ingredient matches for Piromed

Piroxicam

Piroxicam is reported as an ingredient of Piromed in the following countries:

• Belgium

International Drug Name Search

Lidaprim

Lidaprim may be available in the countries listed below.

Ingredient matches for Lidaprim

Sulfametrole

Sulfametrole is reported as an ingredient of Lidaprim in the following countries:

• Austria


• Bosnia & Herzegowina


• Estonia


• Ghana


• Greece


• Guyana


• Hong Kong


• Kenya


• Latvia


• Libya


• Nigeria


• Sudan


• Tanzania


• Zimbabwe

Trimethoprim

Trimethoprim is reported as an ingredient of Lidaprim in the following countries:

• Austria


• Bosnia & Herzegowina


• Estonia


• Ghana


• Greece


• Guyana


• Hong Kong


• Kenya


• Latvia


• Libya


• Nigeria


• Sudan


• Tanzania


• Zimbabwe

International Drug Name Search

Bronkirex

Bronkirex may be available in the countries listed below.

Ingredient matches for Bronkirex

Carbocisteine

Carbocisteine is reported as an ingredient of Bronkirex in the following countries:

• France

International Drug Name Search

Chricetyl

Chricetyl may be available in the countries listed below.

Ingredient matches for Chricetyl

Acetylcysteine

Acetylcysteine is reported as an ingredient of Chricetyl in the following countries:

• Greece

International Drug Name Search

Biocotron

Generic Name: dextromethorphan, guaifenesin

Dosage Form: oral liquid
Drug Facts

Active Ingredients: (in each 5 mL tsp.)              Purpose


Dextromethorphan Hydrobromide 10 mg.................. Cough Suppressant


Guaifenesin 100 mg .............................................. Expectorant

Uses

• temporarily relieves cough due to minor throat and bronchial irritations as may occur with a cold

• helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive

Ask a doctor before use if you have

• cough that occurs with too much phlegm (mucus)


• cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema.

When using this product, do not exceed recommended dosage

Stop use and ask a doctor if cough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. A persistent cough may be a sign of a serious condition.

Do not Use

If you are now taking a prescription monoamine oxidase inhibitor (MAOI)

(certain drugs for depression, psychiatric or emotional conditions or

Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you

do not know if you are taking a prescription drug that contains an MAOI;

ask your doctor or pharmacist before taking this product.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

Directions Do not take more than 6 doses in any 24-hour period, unless directed by a physician

adults and children 12 years and over, 2 teaspoonfuls every 4 hours

children 6 years to under 12 years, 1 teaspoonful every 4 hours

children under 6 years, ask a doctor

Other information store at controlled room temperature

20-25 C (68-77 F); excursion permitted to 15-30 C (59-86 F). Tamper

evident by imprinted heat seal under cap. Do not use if there is

evidence of tampering.

Warning: Phenylketonuric: Contains 11.25 mg of phenylalanine per 5 ml (one teaspoonful) dose.

Inactive ingredients Aspartame, citric acid, flavor, glycerine,

hydroxyethylcellulose, methylparaben, propylene glycol, purified

water and sodium citrate.

Questions or comments? 1-305-403-3788

Manufactured For: Advanced Generic Corporation, Miami, FL 33166.

www.advancedgeneric.com

Biocotron  - dextromethorphan, guaifenesin  liquid

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 45737-209 (65852) Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Dextromethorphan Hydrobromide (Dextromethorphan) Dextromethorphan Hydrobromide 10 mg  in 5 mL Guaifenesin (Guaifenesin) Guaifenesin 100 mg  in 5 mL

Inactive Ingredients Ingredient Name Strength No Inactive Ingredients Found

Product Characteristics Color      Score      Shape Size Flavor CHERRY (Cherry Flavor) Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 45737-209-16 473 mL In 1 BOTTLE None

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part341	01/01/2009

Labeler - Advanced Generic Corporation (831762971)

Revised: 11/2010Advanced Generic Corporation

More Biocotron resources

• Biocotron Side Effects (in more detail)
• Biocotron Dosage
• Biocotron Use in Pregnancy & Breastfeeding
• Biocotron Drug Interactions
• Biocotron Support Group
• 0 Reviews for Biocotron - Add your own review/rating

Compare Biocotron with other medications

• Cough
• Expectoration